Biotest AG
Biotest AG: Biotest AG opens fourth plasma collection centre in Czech Republic
DGAP-News: Biotest AG
/ Key word(s): Miscellaneous
PRESS RELEASE Biotest AG opens fourth plasma collection centre in Czech Republic – 22 plasma collection centres in Europe to ensure long-term plasma supply
Cara Plasma s.r.o. is a 100% subsidiary of Biotest AG and operates four plasma collection centres in the Czech Republic. “We are very happy to be able to open another collecting station in the Czech Republic this year. With the new centre, we are creating 25 highly qualified jobs in the medical sector. Each additional station is an important milestone for us to supply our plasma production facility with the opportunity to support patients worldwide in the fight against diseases”, stated Martin Reinecke, Senior Vice President of Global Plasma Alliances and Protein Supply of Biotest AG. The collected plasma is processed only by Biotest AG at Dreieich, Germany. Regular audits in Czech Republic ensure that the strict legal and internal quality requirements are met. About human blood plasma About Biotest IR contact PR contact Ordinary shares: securities’ ID No. 522720; ISIN DE0005227201 Disclaimer
11.12.2019 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |
Language: | English |
Company: | Biotest AG |
Landsteinerstraße 5 | |
63303 Dreieich | |
Germany | |
Phone: | 0 61 03 – 8 01-0 |
Fax: | 0 61 03 – 8 01-150 |
E-mail: | investor_relations@biotest.de |
Internet: | http://www.biotest.de |
ISIN: | DE0005227235, DE0005227201 |
WKN: | 522723, 522720 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 932897 |
End of News | DGAP News Service |